The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2025

Filed:

Jan. 10, 2018
Applicant:

Sungkwang Medical Foundation, Seoul, KR;

Inventors:

Minyoung Kim, Seoul, KR;

Jee In Choi, Seongnam-si, KR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/51 (2014.12); A61K 9/00 (2005.12); A61K 38/18 (2005.12); C12Q 1/6827 (2017.12); C12Q 1/6851 (2017.12); G01N 33/50 (2005.12);
U.S. Cl.
CPC ...
A61K 35/51 (2012.12); A61K 9/0019 (2012.12); A61K 38/18 (2012.12); C12Q 1/6827 (2012.12); C12Q 1/6851 (2012.12); G01N 33/5023 (2012.12); G01N 2500/04 (2012.12); G01N 2500/10 (2012.12);
Abstract

Provided are a pharmaceutical composition for preventing or treating a central nervous system disease including, as an active ingredient, cord blood or cord blood-derived cells expressing or secreting pericentrin (PCNT), a composition or kit for diagnosing a central nervous system disease including an agent for measuring a level of PCNT protein, a method of analyzing information required for diagnosing a central nervous system disease using PCNT protein, and a method of screening a candidate substance for a therapeutic agent to treat a central nervous system disease. By using the composition including cord blood or cord blood-derived cells expressing or secreting PCNT, central nervous system diseases may be efficiently prevented or treated. Furthermore, the PCNT protein may be used as a target for diagnosing a central nervous system disease at an early stage and for developing a therapeutic agent for a central nervous system disease.


Find Patent Forward Citations

Loading…